ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Can Autoimmune Conditions be Reversed? Researchers Make a Surprising Discovery

How One Tiny Molecule Turned into One Huge Health Breakthrough

Acupuncture boosts effectiveness of standard medical care for chronic pain, depression

Research on Astaxanthin Demonstrates Significant Whole Body Benefits

Nutrients Boost Stem Cell Function

Humans have three times more brown body fat

B12 Proven Essential for Every Cell

Soy isoflavones may benefit breast cancer patients

How B Vitamins Improve Brain Health, Cognition, Psychiatric Problems and Mood Disorders

Dietary prebiotics improve sleep, buffer impacts of stress, says study

 
Print Page
Email Article

Chronic Fatigue Syndrome (CFS) Sufferers Have New Hope for Drugs that Treat Depression and Severe Pain

  [ 30 votes ]   [ Discuss This Article ]
By News Release • www.ProHealth.com • April 7, 2000


Dopamine and somatostatin are two major neurotransmitter systems that share a number of structural and functional characteristics. Dopamine plays a crucial role in a variety of diseases such as Parkinson's disease, schizophrenia and depression, and somatostatin is involved in modulating many of the actions of dopamine such as dopamine-mediated control of motor activity. Receptors for dopamine and somatostatin are frequently located on the surface of the same neuron, thus providing grounds for believing that there is a physiologically relevant interaction between the two systems, both normally and in diseases such as Parkinson's disease, schizophrenia and depression. However, the molecular basis for such interaction is unclear.

In the April 7, 2000 issue of Science, a team of scientists led by Dr. Yogesh Patel, Director of the Division of Endocrinology at the Royal Victoria Hospital and Professor in the McGill Departments of Medicine, Pharmacology and Therapeutics, Neurology and Neurosurgery, shows how this direct intra-membrane association works.

"Many hormones and neurotransmitters regulate cell function by activating surface receptors that belong to a class of proteins known as G protein-coupled receptors (GPCRs) of which there are an estimated 1000 or more in the body," explains Dr. Patel. " In general, GPCRs have been thought to function as single molecules or monomers to which a hormone binds. We have discovered that when a GPCR is activated by its ligand (i.e. its specific hormone or transmitter) it may join physically with another GPCR belonging to a different receptor family to form a hetero-oligomer, a novel receptor whose properties are distinct from that of the two separate receptors."

In Science, Dr.Patel and his team describe an oligomer of dopamine and somatostatin receptors which can be activated to a certain level by either somatostatin or dopamine but which produces a synergistic response when the two ligands are applied simultaneously. "When the complex is exposed to a dopamine antagonist, signaling from both receptors is inhibited," says Dr. Patel. " It is suspected that there are many undiscovered novel receptors like these in the brain and elsewhere in the body made up of hetero-oligomers whose properties are different from those of individual monomers."

"Now," says Dr. Patel," because of the belief that GPCRs are monomers, our current drugs are aimed at monomers, but if we could design future drugs targeted at any of a number of potential hetero-oligomeric receptor combinations such as dopamine and somatostatin receptors, somatostatin and opioid receptors, dopamine and opioid receptors, we could open the door to new drug treatments for many disorders such as Parkinson's disease, schizophrenia, depression, drug addiction, and severe pain."

Source: Eureka Alert



Post a Comment

Featured Products From the ProHealth Store
Ultra ATP+, Double Strength FibroSleep™ Vitamin D3 Extreme™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Strontium - The Missing Mineral for Strong Bones Strontium - The Missing Mineral for Strong Bones
Prepare Yourself for Cold & Flu Season Prepare Yourself for Cold & Flu Season
Vitamin E: Super Antioxidant We Only Thought We Knew Vitamin E: Super Antioxidant We Only Thought We Knew
Reversing Neurodegeneration with a New Magnesium Compound Reversing Neurodegeneration with a New Magnesium Compound
Quercetin: Natural Support for Allergy & Inflammation Relief and More Quercetin: Natural Support for Allergy & Inflammation Relief and More

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map